Influence of the assay for measuring serum albumin on corrected total calcium in chronic hemodialysis patients

Therapeutic Apheresis and Dialysis

Volumn 15, Issue 6, 2011, Pages 540-546

  Kato, Akihiko ^a   Takita, Takako ^b   Furuhashi, Mitsuyoshi ^b   Fujimoto, Taiki ^b   Suzuki, Hiroo ^b   Hakamada, Masahiro ^b   Maruyama, Yukitaka ^b  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Maruyama Hospital   (Japan)

Author keywords

Bromocresol green; Corrected calcium; Hemodialysis; Inflammatory state; Modified bromocresol purple

Indexed keywords

BROMCRESOL PURPLE; BROMOCRESOL GREEN; C REACTIVE PROTEIN; CALCIUM; GLOBULIN; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; ASSAY; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BROMCRESOL GREEN; BROMCRESOL PURPLE; C-REACTIVE PROTEIN; CALCIUM; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, SECONDARY; HYPOCALCEMIA; INDICATORS AND REAGENTS; JAPAN; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RENAL DIALYSIS; SERUM ALBUMIN; SOCIETIES, MEDICAL; YOUNG ADULT;

EID: 82155178471     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2011.00997.x     Document Type: Article

References (21)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(Suppl 3):S1-S201.
2. Guideline Working Group, Japanese Society for Dialysis Therapy. Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients. Ther Apher Dial 2008;12:514-25.
3. Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. Br J Med 1973;4:636-46.
4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int 2009;113(Suppl):S1-S130.
5. K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2000;35(Suppl):S1-S140.
6. Mabuchi H, Nakahashi H. Underestimation of serum albumin by the bromcresol purple method and a major endogenous ligand in uremia. Clin Chem Acta 1987;167:89-96.
7. Wells FE, Addison GM, Postlethwaite RJ. Albumin analysis of haemodialysis patients: discrepancies between bromcresol purple, bromcresol green and electroimmunoassay. Ann Clin Biochem 1985;22:304-9.
8. Carfray A, Patel K, Whitaker P etal. Albumin as an outcome measure in haemodialysis in patients: the effect of variation in assay method. Nephrol Dial Transplant 2000;15:1819-22.
9. Clase CM, St Pierre MW, Churchill DN. Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease. Nephrol Dial Transplant 2001;16:1925-9.
10. Parikh C, Yalavarthy R, Gurevich A etal. Discrepancies in serum albumin measurement vary by dialysis modality. Ren Fail 2003;25:787-96.
11. Muramoto Y, Matsushita M, Irino T. Reduction of reaction differences between human mercaptalbumin and nonmercaptalbumin measured by the bromcresol purple method. Clin Chim Acta 1999;289:69-78.
12. Ono M, Aoki Y, Masumoto M etal. High-dose penicillin G-treatment causes underestimation of serum albumin measured by modified BCP assay. Clin Chem Acta 2009;407:75-6.
13. Yokoyama K, Katoh N, Kasai K etal. The influence of method of calcium concentration and the timing of blood collection on application of the K/DOQI Clinical Practice Guideline for Bone Metabolism and Disease in Japan. Ther Apher Dial 2006;10:257-61.
14. Dewitte K, Fierens C, Stockl D, Thienpont LM. Application of the Bland-Altman plot for interpretation on method-comparison studies: a critical investigation of its practice. Clin Chem 2002;48:799-801.
15. Speicher CE, Widish JR, Gaudot FJ, Hepler BR. An evaluation of the overestimation of serum albumin by bromcresol green. Am J Clin Pathol 1978;69:347-50.
16. Joseph R, Tria L, Mossey RT etal. Comparison of methods for measuring albumin in peritoneal dialysis and hemodialysis patients. Am J Kidney Dis 1996;27:566-72.
17. Labriola L, Wallemarcq P, Gulbis BM, Jadoul M. The impact of the assay for measuring albumin on corrected ("adjusted") calcium concentrations. Nephrol Dial Transplant 2009;24:1834-8.
18. Gauci C, Moranne O, Fouquerqy B etal. Pitfalls of measuring total blood calcium in patients with CKD. J Am Soc Nephrol 2008;19:1592-8.
19. Clase CM, Norman GL, Beecroft ML etal. Albumin-corrected calcium and ionized calcium in stable haemodialysis patients. Nephrol Dial Transplant 2000;15:1841-6.
20. Goransson LG, Skadberg O, Bengrem H. Albumin-corrected or ionized calcium in renal failure? What to measure? Nephrol Dial Transplant 2005;20:2126-9.
21. Ferrari P, Singer R, Agarwal A etal. Serum phosphate is an important determination of corrected serum calcium in end-stage kidney disease. Nephrology 2009;14:383-8.